Teva Pharmaceutical Industries Limited
Teva Pharmaceutical Industries Limited (NYSE: TEVA) is trading at $39.19, about ₹3,759 at today's USD/INR rate, as of 25 Sep 2026, 4:00 PM ET, down 2.56% today. Indian residents can buy Teva Pharmaceutical Industries from India on Paasa under the RBI's Liberalised Remittance Scheme.
Quote
Today's low
$38.93
Today's high
$40.25
52 week low
$18.27
52 week high
$40.79
TEVA opened at $40.10, closed previously at $40.22, and has traded between $18.27 and $40.79 over the past 52 weeks.
About
Teva Pharmaceutical Industries Limited functions as a global pharmaceutical enterprise, involved in the conception, manufacturing, marketing, and provision of a broad spectrum of generic, specialty, and biopharmaceutical products throughout North America, Europe, and various international markets. The company's diverse product range includes sterile items, hormones, potent drugs, and cytotoxic agents, available in numerous forms like tablets, capsules, injectable solutions, inhalable preparations, liquids, transdermal patches, topical ointments, and creams. Additionally, Teva develops, produces, and sells active pharmaceutical ingredients (APIs). The firm prioritizes several key therapeutic domains: central nervous system disorders, pain management, respiratory ailments, and oncology. In the central nervous system sector, prominent products include Copaxone, intended for relapsing forms of multiple sclerosis; AJOVY, prescribed for preventing migraines; and AUSTEDO, which targets tardive dyskinesia and chorea linked to Huntington's disease. For respiratory conditions, Teva offers medications such as ProAir, QVAR, ProAir Digihaler, AirDuo Digihaler, ArmonAir Digihaler, BRALTUS, CINQAIR/CINQAERO, DuoResp Spiromax, and AirDuo RespiClick/ArmonAir RespiClick, all designed to treat asthma and chronic obstructive pulmonary disease. The oncology portfolio features therapies like Bendeka, Treanda, Granix, Trisenox, Lonquex, and Tevagrastim/Ratiograstim. Teva Pharmaceutical Industries Limited is also engaged in a collaboration with MedinCell to advance and commercialize multiple long-acting injectable formulations, notably a risperidone suspension for individuals affected by schizophrenia. The company was established in 1901 and its primary headquarters are located in Tel Aviv-Yafo, Israel.
Key statistics
Avg. volume
5.56M
Market cap
$45.64B
P/E Ratio
62.74
Price-to-sales ratio
2.65
Enterprise value
$59.16B
Free cash flow yield
5.17%
Debt-to-equity ratio
2.16
Return on equity
9.18%
ROIC
9.00%
Beta
0.87
Dividend yield
0.00%
Last dividend
$0.00
Financial overview
Revenue
$17.26B
Earnings per share
$1.23
Free cash flow
$1.15B
Net profit margin
4.12%
Gross margin
52.46%
EBITDA
$3.14B
Revenue growth
4.31%
Similar securities
This is not an investment recommendation
How to buy Teva Pharmaceutical Industries from India
Indian residents can buy Teva Pharmaceutical Industries shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers.
Open a Paasa account
Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Add funds under LRS
Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars.
Search for Teva Pharmaceutical Industries and place an order
Find Teva Pharmaceutical Industries by name or by its ticker, TEVA, and choose an order type. You can buy by amount or by quantity — fractional shares mean there is no minimum trade size. Teva Pharmaceutical Industries trades 7:00 pm – 1:30 am IST; orders can only execute during that window.
Track holdings and download tax reports
Follow your Teva Pharmaceutical Industries position in USD and INR. Teva Pharmaceutical Industries pays no dividend today, so your filing is the capital-gains statement plus the Schedule FA holding line.
Read the full guide: how to invest in Teva Pharmaceutical Industries from India
Trading and taxes when buying Teva Pharmaceutical Industries from India
Trading and limits
- Trading hours
- 9:30 am – 4:00 pm ET
- LRS limit
- $250,000Per financial year, under the RBI's Liberalised Remittance Scheme.
Tax for Indian residents
- TCS on remittance
- 20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
- Capital gains in India
- 12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
- Dividends
- NoneTeva Pharmaceutical Industries does not currently pay a dividend. If it starts, dividends are taxed at your slab rate in India.Dividend tax explained
Custody. Shares are held in your own name at Interactive Brokers LLC and are SIPC-insured up to $500,000 in total, including $250,000 for cash.
FAQs
Can Indian residents buy Teva Pharmaceutical Industries stock?
Yes. Teva Pharmaceutical Industries (TEVA) has been listed on the New York Stock Exchange since 1982, in the Drug Manufacturers - Specialty & Generic industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars. Shares are held in your own name at Interactive Brokers LLC and are SIPC-insured up to $500,000 in total, including $250,000 for cash.
How much does one Teva Pharmaceutical Industries share cost in rupees?
One Teva Pharmaceutical Industries share is $39.19 — about ₹3,759 at a USD/INR rate of 95.92 on 25 Sep 2026. Both the Teva Pharmaceutical Industries price and the rupee rate move during the day, so the rupee cost changes with them.
What are the LRS and TCS rules for buying Teva Pharmaceutical Industries from India?
Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.
Can I buy whole shares of Teva Pharmaceutical Industries?
Yes. One Teva Pharmaceutical Industries share is $39.19, and you can buy as many whole shares as you like. You can also buy by amount rather than by quantity: there is no minimum trade size, and Paasa supports fractional investing in Teva Pharmaceutical Industries.
How are gains on Teva Pharmaceutical Industries shares taxed in India?
The US does not levy capital gains tax on shares for Indian residents, so the tax is an India-side one. Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the USD/INR rate on the purchase and the sale date, so the rupee move counts alongside the Teva Pharmaceutical Industries price. Paasa issues a capital-gains statement for your return.
Does Teva Pharmaceutical Industries pay a dividend?
No. Teva Pharmaceutical Industries does not currently pay a dividend, so holding it produces no dividend income to declare in India. If it starts paying one, the Indian treatment is the usual one — dividends are taxed at your slab rate in India — and Paasa's dividend report would show the gross amount and any tax withheld.
When can I trade Teva Pharmaceutical Industries from India?
The New York Stock Exchange trades 7:00 pm – 1:30 am IST in Indian time, so the close lands after midnight. The window shifts to 8:00 pm – 2:30 am IST when the US is on standard time. Orders can only execute during that window.
Is Teva Pharmaceutical Industries a United States company, and does that change how it is taxed?
Teva Pharmaceutical Industries trades on the New York Stock Exchange in US dollars, but the company is domiciled in Israel. Teva Pharmaceutical Industries trades as an American Depositary Receipt rather than an ordinary share. Some non-US companies list in the US through American Depositary Receipts, which can carry dividend withholding at the company's home-country rate. Your India-side capital-gains treatment is the same either way.
Do I have to declare Teva Pharmaceutical Industries shares in my Indian tax return?
Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your Teva Pharmaceutical Industries holding, its cost and its closing value.
How do I sell Teva Pharmaceutical Industries and bring the money back to India?
You sell during market hours (7:00 pm – 1:30 am IST) and the proceeds settle in USD in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.